Modified dissolution method
A glass beaker (100-ml capacity) was modified at the base by adding an S-shaped glass tube so that the glass beaker can hold 70 ml of dissolution medium. The medium was stirred on a magnetic stirrer. A burette was mounted above the beaker to deliver the dissolution medium at a flow rate of 2 ml/min.
Dissolution study of carbamazepine tablets
The carbamazepine tablet was put in the modified beaker containing 70 ml of 0.1 N HCl. After about 2 min, the time required for floating of the tablet, the contents were stirred at a speed of 75 rpm. The temperature of the dissolution medium was maintained at 37 ± 0.5 °C. From a burette, 0.1 N HCl was added at the rate of 2 ml/min. The dissolution medium along with the dissolved drug came out of the side arm provided at the base of the beaker at the rate of 2 ml/min. Samples of 5 ml were collected at a
Abstract
The study objective was to develop a more relevant in vitro dissolution method to evaluate a carbamazepine floating drug delivery system. A 100-mL glass beaker was modified by adding a side arm at the bottom of the beaker so that the beaker can hold 70 ml of 0.1 N HCl dissolution medium and allow collection of samples. A burette was mounted above the beaker to deliver the dissolution medium at a flow rate of 2 mL/min to mimic gastric acid secretion rate. Carbamazepine floating tablets were prepared by wet granulation technique. The performance of the modified dissolution apparatus was compared with USP dissolution Apparatus 2 (Paddle). The problem of adherence of the tablet to the shaft of the paddle was observed with the USP dissolution apparatus. The tablet did not stick to the agitating device in the proposed dissolution method. The drug release followed zero-order kinetics in the proposed method. Similarity of dissolution curves was observed between the USP method and the proposed method at 10% difference level (f 2 =57). However, the dissolution profiles were found to be dissimilar at 5% level. The proposed test may show good in vitro-in vivo correlation since an attempt is made to mimic the in vivo conditions such as gastric volume, gastric emptying, and gastric acid secretion rate. specific time interval (e.g. 30, 60, 120, 180, 240, 360, 480, 600 and 720 min) to analyze the drug content in the dissolution medium. All the samples were passed through a 0.5 µm filter paper and then analyzed using UV/Vis spectrophotometer (Hitachi U2000, Japan) at 285 nm. The dissolution study was also carried out using USP dissolution Apparatus 2 (Paddle, 900 mL 0.1 N HCl, 37 ± 0.5 °C , 75 rpm).
Results and discussion Carbamazepine floating tablets
Carbon dioxide is formed within the tablet containing effervescent agent when the carbamazepine tablet is brought in contact with the acidic dissolution medium. The low density of hydroxypropyl methylcellulose assists in floating the carbamazepine tablet. . Moreover, the gelling capacity of HPMC also helps float the tablet by entrapping carbon dioxide gas in the gel network of HPMC. The gelling capacity of HPMC prevents disintegration of the tablet during the dissolution study and thus sustained drug release occurs. The formulation shown in the experimental section is an optimum formulation selected from a simplex lattice design. The tablets showed a lag time, the time required for flotation of the tablet was 2 minutes.
Modified dissolution apparatus
The proposed method is essentially a modification of the Rossett-Rice test (10) , which is a popular in vitro test for evaluating the acid neutralization efficiency of antacids. Antacids are short acting compounds and therefore the Rossett-Rice test is carried out in a conventional beaker for a period of about 30-60 minutes, while the floating drug delivery systems are generally meant for obtaining sustained effect and therefore modification is necessary at the bottom of the beaker. In the proposed method, a gastric emptying phenomenon is mimicked by providing a side arm at the bottom of the beaker. The test also tries to simulate the conditions of a flow-through cell with respect to availability of fresh dissolution medium around the dosage form. High stirring rate (300 rpm) is used in the Rossett-Rice test as compared to the current practice of low speed stirring (50-100 rpm) in the USP paddle apparatus. In short, the modified test tries to mimic the gastric volume (70 ml), gastric acid secretion rate (2 ml/min) and emptying of liquid through pylorus opening. Figures I and II depict the schematic representation of the modified dissolution vessel and Rossett-Rice method respectively. Figure III and Table I show that the drug was released at a slightly slower rate in the proposed method as compared to USP dissolution apparatus 2 at the earlier sampling times. At the later sampling time points, the drug was released at a slightly faster rate in the proposed method as compared to the USP method. Furthermore, a more linear drug release and a higher total amount of drug release were achieved in the proposed method (95.8% of drug release by the proposed method as compared to 85.0% of drug release by the USP method). The proposed method allowed easy sampling and eliminated the tablet sticking to the agitating device (magnetic stirrer). The proposed test may show good in vivo in vitro correlation since an attempt is made to mimic the in vivo conditions. The results of in vitro drug dissolution were fitted to zero order model. The values of correlation coefficient were found to be 0.99 and 0.95 respectively with the proposed method and USP method. The calculated values of time for 50% drug release (t 50 ) and 80% drug release (t 80 ) were found to be 397 and 642 minutes respectively. Table II shows the comparison between the different dissolution methods (11, 12) . Table III contrasts the features of the Rossett-Rice test and the proposed method.
Dissolution testing
Moore and Flanner (13) proposed an equation for calculating similarity factor (f 2 ). Value of f 2 between 50 and 100 ensures sameness or equivalence of the two dissolution profiles (14) . The calculated value of f 2 was 57, indicating similarity at 10% difference between USP method (reference) and proposed method (test). Shah et al. (15) reported that f 2 equal to 65 indicates similarity at 5% difference. Therefore, at 5% difference, the dissolution profiles cannot be considered as similar.
Two-tiered dissolution tests in simulated gastric fluid with or without pepsin may be adopted in the proposed method. Further studies may be carried out with a different rate of HCl addition (2-4 ml/min), with a different volume of HCl in the beaker (up to 100 ml) and with a different agitation rate.
Conclusion
In the present study, a novel in vitro dissolution test methodology is proposed wherein the gastric acid secretion rate, gastric volume and gastric emptying are mimicked. The proposed method showed dissimilar dissolution with respect to USP method 2 at 5% difference. The dosage form is surrounded by fresh dissolution medium as seen in a flow-through cell. Throughout the study, sticking of the tablet to the agitation device was not observed. Hence, minimum variation between and within batches may be expected. The test allowed easy sampling. The drug release in the proposed method followed zero-order kinetics. The proposed test may be adopted as a quality control test or for establishing in vitro in vivo correlation. Academicians and researchers may adopt this method due to its simplicity. The proposed method can also be used for other drugs such as ciprofloxacin, cizapride, diltiazem, misoprostol, diazepam, L-Dopa, furosemide, captopril, metronidazole, and so on, which are potential candidates for a floating drug delivery system.
